Unlike previous studies in the literature, in this study, oxidant (MDA, TOS, OSI) and antioxidant (SOD, GSH, TAS) biomarkers were analyzed separately quantitatively in serum and erythrocyte samples of individuals with HBV and HCC, and the correlation of these parameters with liver damage markers was evaluated. This evidence concerns the gene SOD1 and hepatocellular carcinoma.